CytoSorbents Corporation (CTSO)

[cars100cars]

KITE might be receptive now to using CytoSorb with CAR-T treatments. Notice how KITE dropped like a stone yesterday. One patient in 300 person CAR-T studied died. It was the result of excessive inflammation. Very weak and very ill patient with no other options left, so he tried CAR-T treatment. Guy expired in two days. KITE's product is a good one, and will likely still be on track for FDA approval. But the issue remains that CAR-T treatment can elevate inflammation to an extreme level. CytoSorb is a possible solution to mitigate inflammation without complicating matters with additional drugs. CTSO's new hire with CAR-T background might be on the phone to KITE today????